Co-deletion of ATAD1 with PTEN primes cells for BIM-mediated apoptosis
Winter, J. M.; Fresenius, H. L.; Keys, H. R.; Cunningham, C. N.; Ryan, J.; Sirohi, D.; Berg, J. A.; Tripp, S. R.; Barta, P.; Agarwal, N.; Letai, A.; Sabatini, D. M.; Wohlever, M. L.; Rutter, J.
Show abstract
PTEN is a potent tumor suppressor gene that is frequently mutated or deleted in human cancers. Such deletions often include portions of the 10q23 locus beyond the bounds of PTEN itself, in many cases resulting in the disruption of additional genes. Coincidental loss of PTEN-adjacent genes might impose vulnerabilities that could either affect patient outcome basally or be exploited therapeutically. Here we describe how the loss of ATAD1, which is adjacent to and frequently co-deleted with PTEN, predisposes cancer cells to apoptosis and correlates with improved survival in cancer patients. ATAD1 directly and specifically extracts the pro-apoptotic BIM protein from mitochondria to inactivate it. Cells lacking ATAD1 are hypersensitive to clinically used proteasome inhibitors, which increase BIM and trigger apoptosis. Thus, we demonstrate that mitochondrial protein quality control interfaces with cell death in a clinically actionable manner.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- PTP1B is an intracellular checkpoint that limits T cell and CAR T cell anti-tumor immunity 96%
- Increased RNA and protein degradation is required for counteracting transcriptional burden and proteotoxic stress in human aneuploid cells 95%
- Melanoma-secreted Amyloid Beta Supresses Neuroinflammation and Promotes Brain Metastasis 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.